📊 SRXH Key Takeaways
Is SRx Health Solutions, Inc. (SRXH) a Good Investment?
SRx Health Solutions exhibits terminal financial distress with operating losses exceeding revenue (-135% operating margin), negative operating cash flow, and unsustainable cash burn. The company is destroying shareholder value (ROE -244%) and faces critical liquidity constraints (current ratio 0.80x) that will exhaust cash reserves within 12-18 months at current burn rates.
Why Buy SRx Health Solutions, Inc. Stock? SRXH Key Strengths
- Gross margin of 37.5% indicates core product viability if operational overhead could be controlled
- Cash position of $13.1M provides temporary liquidity buffer for restructuring attempts
- Modest insider activity (2 Form 4 filings/90 days) suggests management retention without panic selling
SRXH Stock Risks: SRx Health Solutions, Inc. Investment Risks
- Operating loss of $3.8M exceeds total revenue of $2.8M - fundamentally unsustainable economics
- Negative operating cash flow of -$2.9M indicates core business is burning cash, not generating value
- Current ratio 0.80x creates acute liquidity crisis; current assets insufficient to cover current liabilities
- Debt-to-equity ratio of 1.26x combined with negative profitability and cash burn creates imminent default risk
- Revenue base of $2.8M is insufficient to support operating expenses of $6.6M - structural viability question
Key Metrics to Watch
- Operating cash flow - must achieve positive cash generation from operations to survive
- Revenue growth and cost structure - path to gross profit coverage of operating expenses
- Cash runway - months of operations remaining before liquidity depletion at current burn rate
SRx Health Solutions, Inc. (SRXH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
SRXH Profit Margin, ROE & Profitability Analysis
SRXH vs Consumer Sector: How SRx Health Solutions, Inc. Compares
How SRx Health Solutions, Inc. compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is SRx Health Solutions, Inc. Stock Overvalued? SRXH Valuation Analysis 2026
Based on fundamental analysis, SRx Health Solutions, Inc. shows some fundamental concerns relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
SRx Health Solutions, Inc. Balance Sheet: SRXH Debt, Cash & Liquidity
SRXH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: SRx Health Solutions, Inc.'s revenue has declined by 86% over the 5-year period, indicating business contraction. The most recent EPS of $-1.95 indicates the company is currently unprofitable.
SRXH Revenue Growth, EPS Growth & YoY Performance
SRXH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.8M | -$4.0M | $-0.17 |
| Q3 2025 | $11.4M | -$3.1M | $-0.14 |
| Q1 2025 | $7.2M | -$964.0K | $-0.37 |
| Q3 2024 | $2.0M | $1.3M | $0.73 |
| Q2 2024 | $8.5M | -$176.0K | $-0.21 |
| Q1 2024 | $7.9M | -$2.8M | $-3.60 |
| Q3 2023 | $11.9M | -$1.6M | $-0.05 |
| Q2 2023 | $10.5M | -$3.0M | $-0.10 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
SRx Health Solutions, Inc. Dividends, Buybacks & Capital Allocation
SRXH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for SRx Health Solutions, Inc. (CIK: 0001471727)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SRXH
What is the AI rating for SRXH?
SRx Health Solutions, Inc. (SRXH) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SRXH's key strengths?
Claude: Gross margin of 37.5% indicates core product viability if operational overhead could be controlled. Cash position of $13.1M provides temporary liquidity buffer for restructuring attempts.
What are the risks of investing in SRXH?
Claude: Operating loss of $3.8M exceeds total revenue of $2.8M - fundamentally unsustainable economics. Negative operating cash flow of -$2.9M indicates core business is burning cash, not generating value.
What is SRXH's revenue and growth?
SRx Health Solutions, Inc. reported revenue of $2.8M.
Does SRXH pay dividends?
SRx Health Solutions, Inc. does not currently pay dividends.
Where can I find SRXH SEC filings?
Official SEC filings for SRx Health Solutions, Inc. (CIK: 0001471727) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SRXH's EPS?
SRx Health Solutions, Inc. has a diluted EPS of $-0.26.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is SRXH a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, SRx Health Solutions, Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is SRXH stock overvalued or undervalued?
Valuation metrics for SRXH: ROE of -244.4% (sector avg: 18%), net margin of -306.9% (sector avg: 8%). Compare these metrics with sector averages to assess valuation.
Should I buy SRXH stock in 2026?
Our dual AI analysis gives SRx Health Solutions, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SRXH's free cash flow?
SRx Health Solutions, Inc.'s operating cash flow is $-2.9M, with capital expenditures of $7.0K. FCF margin is -104.3%.
How does SRXH compare to other Consumer stocks?
Vs Consumer sector averages: Net margin -306.9% (avg: 8%), ROE -244.4% (avg: 18%), current ratio 0.80 (avg: 1.5).